This report offers an in-depth analysis of the contract research organization (CRO) industry, categorized by geography, therapeutic area, and phase of development for Q1 2026.
Report Scope
- The Q1 2026 CRO Activity and Intel report offers insights into CRO and sponsor activity, clinical trial trends, and geographical performance across various therapeutic areas.
Reasons to Buy
This report will enable the user to answer the following questions:
- What are the trends by region, therapy area, sites by CROs for the past quarter?
- Who was the most active CRO in the past quarter?
- Who were the most active sponsors by market cap in the past quarter?
- What was the most widely studied therapy area in the past quarter vs. the previous quarter?
- By region, who had the most clinical trials initiated in the past quarter?
- By region, what were the Q1 2026 CRO invitations and appointments?
Table of Contents
- About the Analyst
- Introduction
- Global
- North America
- Europe
- Rest of the World
- Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ICON
- IQVIA Holdings
- PPD
- Parexel International
- Labcorp Drug Development
- Clario
- The Nucleus Network Pty Ltd
- Syneos Health
- Fortrea Holdings
- Spinos Life Science and Research Pvt Ltd
- AstraZeneca Plc
- Merck & Co Inc
- Eli Lilly and Co
- Pfizer Inc
- Jiangsu Hengrui Pharmaceuticals Co Ltd
- Bristol Myers Squibb Co
- Novartis AG
- Regeneron Pharmaceuticals Inc
- AbbVie Inc
- CSPC Pharmaceutical Group Ltd
- Shanghai Henlius Biotech Inc
- Haisco Pharmaceutical Group Co Ltd
- Syndax Pharmaceuticals Inc
- Gan & Lee Pharmaceuticals Co Ltd
- Hanmi Pharmaceuticals Co Ltd
- Simcere Pharmaceutical Group Ltd
- Zydus Lifesciences Ltd
- Dizal Pharmaceutical Co Ltd
- Ideaya Biosciences Inc
- InnoCare Pharma Ltd
- Chong Kun Dang Pharmaceutical Corp.
- Alphamab Oncology
- Cisen Pharmaceutical Co Ltd
- Philogen SpA
- Boryung Co Ltd
- Daewon Pharmaceutical Co Ltd
- FDC Ltd
- Luye Pharma Group Ltd
- Radiopharm Theranostics Ltd
- AFT Pharmaceuticals Ltd
